KKR & Co Inc (KKR) has acquired a large stake in Henry Schein (HSIC) and plans to work with the medical- and dental-supply company to boost its operations, The Wall Street Journal reported Wednesday, citing unnamed people familiar with the matter.
The private equity firm plans to reveal an agreement that includes raising its stake in Henry Schein to 12% with an option to buy a further 2.9% in the future, the sources told WSJ.
Henry Schein has also agreed to give the KKR two board seats, with a representative from KKR joining a board committee that has been working on CEO succession planning, according to the report.
KKR and Henry Schein did not immediately respond to MT Newswires' request for comment on the matter.
(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。